About ReadCoor
ReadCoor is a company based in Cambridge (United States) founded in 2016 was acquired by 10X Genomics in October 2020.. ReadCoor has raised $55.61 million across 5 funding rounds from investors including 10X Genomics, The Chan Zuckerberg Initiative and Gates Foundation. ReadCoor operates in a competitive market with competitors including Nanopore, PacBio, Alnylam, Omniome and Complete Genomics, among others.
- Headquarter Cambridge, United States
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Readcoor, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$55.61 M (USD)
in 5 rounds
-
Latest Funding Round
$30 M (USD), Series B
Jan 01, 2020
-
Investors
10X Genomics
& 8 more
-
Employee Count
Employee Count
-
Acquired by
10X Genomics
(Oct 05, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ReadCoor
ReadCoor has successfully raised a total of $55.61M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $30.0M
-
First Round
First Round
(28 Sep 2016)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Series B - ReadCoor | Valuation | Pavilion Capital Partners | |
| Jul, 2019 | Amount | Series A - ReadCoor | Valuation |
investors |
|
| Jan, 2018 | Amount | Grant - ReadCoor | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ReadCoor
ReadCoor has secured backing from 9 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include 10X Genomics, The Chan Zuckerberg Initiative and Gates Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage companies are invested in by this venture capital fund.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science and technology sectors
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ReadCoor
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ReadCoor
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Readcoor Comparisons
Competitors of ReadCoor
ReadCoor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Alnylam, Omniome and Complete Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| domain | founded_year | HQ Location |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
DNA sequencing platform for human genome analysis is developed.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Readcoor
Frequently Asked Questions about ReadCoor
When was ReadCoor founded?
ReadCoor was founded in 2016.
Where is ReadCoor located?
ReadCoor is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is ReadCoor a funded company?
ReadCoor is a funded company, having raised a total of $55.61M across 5 funding rounds to date.
What does ReadCoor do?
ReadCoor was founded in 2016 in Cambridge, United States, within the biotechnology sector. A next-generation sequencing platform is being developed and commercialized, allowing high-throughput RNA sequencing alongside preservation of sample morphology and integration of spatial imaging data. FISSEQ technology supports applications in drug development, pathogen identification, disease diagnostics, regenerative medicine, immuno-oncology, gene therapy, and brain diseases, originating from Harvards Dr. Church lab.
Who are the top competitors of ReadCoor?
Who are ReadCoor's investors?
ReadCoor has 9 investors. Key investors include 10X Genomics, The Chan Zuckerberg Initiative, Gates Foundation, DAF Trucks, and Pavilion Capital Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.